Annual report pursuant to Section 13 and 15(d)

Related Party Matters (Details)

v3.22.1
Related Party Matters (Details)
4 Months Ended 12 Months Ended
Oct. 11, 2021
USD ($)
Aug. 10, 2020
USD ($)
$ / shares
shares
Dec. 19, 2019
USD ($)
Apr. 30, 2021
agreement
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Related Party Transaction [Line Items]            
Research and development         $ 2,931,437 $ 1,944,411
Emerald Health Pharmaceuticals | Month To Month Lease Agreement            
Related Party Transaction [Line Items]            
Sublease rent         4,000  
Costs and expenses, related party         15,453  
Emerald Health Biotechnology Espana, S.L.U. | Collaborative Research Agreement            
Related Party Transaction [Line Items]            
Number of collaborative research agreements | agreement       2    
Initial term of research agreement       1 year    
Termination terms, period following uncured breach       45 days    
Research and development         220,418  
Related party prepaid asset         8,056  
Emerald Health Biotechnology Espana, S.L.U. | Collaborative Research Agreement | Emerald Health Research, Inc            
Related Party Transaction [Line Items]            
Ownership percentage       100.00%    
Independent Contractor Agreement            
Related Party Transaction [Line Items]            
Accrued expense under agreement         0 7,032
Independent Contractor Agreement | Dr. Avtar Dhillon            
Related Party Transaction [Line Items]            
Accrued expense under agreement           10,000
Monthly fee     $ 10,000      
Fees incurred under agreement         94,516 $ 127,387
Number of shares issued in transaction (in shares) | shares   500,000        
Sale price (in dollars per share) | $ / shares   $ 0.10        
Extinguishment of debt   $ 50,000        
Independent Contractor Agreement | Officers, Employees and Directors            
Related Party Transaction [Line Items]            
Number of shares issued in transaction (in shares) | shares   1,566,666        
Sale price (in dollars per share) | $ / shares   $ 0.10        
Extinguishment of debt   $ 186,667        
Exclusive Sponsored Research Agreement | EHBE            
Related Party Transaction [Line Items]            
Costs and expenses, related party         44,624  
Initial term of research agreement 1 year          
Related party prepaid asset         $ 5,376  
Annual retainer amount $ 200,000          
Renewal term of research agreement 1 year          
Notice period for termination 60 days